CLINICAL_TRIALS
trial_result
· 2020-08-26
Clinical Trial Update: Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB [Phase 1]
Summary
Phase 1 study reporting mass balance, pharmacokinetics, and metabolism of ixazomib in patients with advanced solid tumors and lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Solid Tumors, Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2020-08-26